Disopyramide: Six Years' Experience
- 1 June 1983
- journal article
- clinical trial
- Published by SAGE Publications in Angiology
- Vol. 34 (6) , 367-374
- https://doi.org/10.1177/000331978303400601
Abstract
Since its approval by the FDA six years ago, oral disopyramide has earned a recognized role in the treatment of ventricular arrhythmias. During this time, clinical experience has refined our knowledge of this agent, allowing revision of dosing guidelines and better selection of patients. This review explores the recent therapeutic experience with disopyramide.Keywords
This publication has 34 references indexed in Scilit:
- Disopyramide-Induced Heart BlockChest, 1981
- Disopyramide phosphate in wolff-parkinson-white syndromeThe American Journal of Cardiology, 1981
- Chronic Longterm Electrophysiologic Study of Paroxysmal Ventricular TachycardiaChest, 1980
- Electrophysiological effects of disopyramide phosphate during experimental myocardial ischemiaAmerican Heart Journal, 1979
- Disopyramide in Patients with the Wolff-Parkinson-White Syndrome and Atrial FibrillationChest, 1978
- Disopyramide: Serum level and arrhythmia conversionAmerican Heart Journal, 1976
- ORAL DISOPYRAMIDE IN PROPHYLAXIS OF ARRHYTHMIAS FOLLOWING MYOCARDIAL INFARCTIONThe Lancet, 1976
- Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.Heart, 1975
- Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphateThe American Journal of Cardiology, 1975
- Electrophysiological evaluation of disopyramide in manAmerican Heart Journal, 1973